Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts

Clinical trial NCT05415241 · UNKNOWN

Trial details

NCT number: NCT05415241
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Close Contact Transmission

Start date: 2022-06-09
Primary completion: 2022-08-09
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.